Chronic Kidney Disease News

Patients’ desire to help others and learn more about their kidney disease rated higher than financial incentives when it came to study enrollment, recently published data show.

A new study looking at data from a private health plan found costs for kidney drugs in patients on hemodialysis were twofold higher compared to patients on peritoneal dialysis.

Results from a study completed in eight European countries showed that patients receiving high-dose hemodiafiltration had lower mortality vs. patients using high-flux dialysis.

Among more than 250,000 patients hospitalized for HF for the first time in four countries, more than one-quarter died within 1 year of their hospitalization, according to the EVOLUTION HF cohort study.

A new patient-guided telehealth intervention may relieve fatigue and pain in patients on long-term hemodialysis for end-stage kidney disease, recently published data show.

Discontinuing or reducing renin-angiotensin-aldosterone system inhibitor treatment may have negative outcomes for patients with hyperkalemia, but it is a common practice in many clinics, according to recently presented research.

Using DNA methylation markers in blood samples may help predict the progression of diabetic kidney disease in patients with type 2 diabetes, recent data suggests.

Measuring time to kidney failure in advanced chronic kidney disease can inform clinical decisions and patient counseling, regardless of estimates based on eGFR or the kidney failure risk equation, according to recently published data.

Medicare Advantage enrollees with mildly reduced kidney function and accelerated eGFR decline have disproportionately higher medical costs than other patients, data show.

SGLT2 inhibitors reduce risk for CV death and HF events in patients with any or multiple of HF, type 2 diabetes and chronic kidney disease, according to a meta-analysis published in the Journal of the American College of Cardiology.